Toni Rinow
Director/Board Member at SPROUT AI INC.
Net worth: 31 024 $ as of 2024-04-29
Profile
Dr. Toni Rinow is an Independent Director at Converge Technology Solutions Corp.
and an Independent Director at Sprout AI, Inc. She is on the Board of Directors at Converge Technology Solutions Corp.
and Sprout AI, Inc. Dr. Rinow was previously employed as a Chief Financial Officer by SANUWAVE Health, Inc., a Chief Operating Officer & Secretary by Neptune Wellness Solutions, Inc., a Chief Executive Officer by BetterLife Pharma, Inc., a General Manager by Jubilant DraxImage, Inc., a Senior Vice President by Fonds de Solidarité FTQ, a Vice President-Corporate Development by MethylGene, Inc., a Senior Analyst-Business Development by ConjuChem, Inc., a Chief Operating Officer by Isologic Innovative Radiopharmaceuticals Ltd., a Director-Corporate Development by Neptune Wellness Solutions, Inc., and a Medical Representative by Smithkline Beecham Plc.
She received her undergraduate degree from the University of Strasbourg, a graduate degree from McGill University, an MBA from McGill University and a doctorate degree from the University of Montréal.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-21 | 7,604 ( 0.00% ) | 31 024 $ | 2024-04-29 |
Toni Rinow active positions
| Companies | Position | Start |
|---|---|---|
| SPROUT AI INC. | Director/Board Member | 2022-04-10 |
| CONVERGE TECHNOLOGY SOLUTIONS CORP. | Director/Board Member | 2022-06-22 |
Former positions of Toni Rinow
| Companies | Position | End |
|---|---|---|
| SANUWAVE HEALTH, INC. | Director of Finance/CFO | 2024-03-27 |
| BETTERLIFE PHARMA INC. | Chief Executive Officer | 2020-01-21 |
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Corporate Officer/Principal | 2018-12-31 |
Fonds de Solidarité FTQ
 Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Private Equity Investor | 2008-03-30 |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 2004-10-29 |
Training of Toni Rinow
| McGill University | Graduate Degree |
| University of Montréal | Doctorate Degree |
| University of Strasbourg | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| NEPTUNE WELLNESS SOLUTIONS INC. | Health Technology |
| BETTERLIFE PHARMA INC. | Health Technology |
| SPROUT AI INC. | Producer Manufacturing |
| CONVERGE TECHNOLOGY SOLUTIONS CORP. | Technology Services |
| SANUWAVE HEALTH, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Finance |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
ConjuChem, Inc.
 ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Health Technology |
Isologic Innovative Radiopharmaceuticals Ltd.
 Isologic Innovative Radiopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Isologic Innovative Radiopharmaceuticals Ltd. operates as a radiopharmaceutical company. The company is headquartered in Burlington, Canada. | Health Technology |
- Stock Market
- Insiders
- Toni Rinow
